Home > Resources > Whitepapers > An Editorial Mission: CRISPR Targets Animal Models

An Editorial Mission: CRISPR Targets Animal Models

November 6, 2018

CRISPR genome-editing technology is only five years old, but it has already made remarkable strides in biomedical, microbial, and agricultural research. CRISPR affords scientists the ability to edit multiple genes at once in any extant organism, which is especially relevant for generating in vivo model systems for pathologies like cancer. With CRISPR, researchers can now easily tailor the genome of an organism to suit their needs, with minimal prior animal model development experience required.

Spotlight

SingHealth

The SingHealth Duke-NUS Academic Medical Centre draws on the collective strengths of SingHealth and Duke-NUS Medical School to drive the transformation of healthcare and provide affordable, accessible, quality healthcare. With over 40 clinical specialties, a network of acute hospitals, national specialty centres, polyclinics and community hospitals, it delivers comprehensive, multi-disciplinary and integrated care. To enhance community care, the new Outram Community Hospital on SGH Campus will be completed in 2020.

OTHER WHITEPAPERS

Validation of ICON™ Automated Cell Counting and Viability Assay

whitePaper | August 10, 2022

Determination of cell viability and concentration using trypan blue exclusion is essential for biotherapeutic workflows, enabling optimisation of protocols, monitoring of changes to the culture environment, and selection of the best clones for culture progression.